Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the ClearSight™ System to Evaluate the Ability to Distinguish Malignant From Non-malignant Breast Tissue by Comparing MR Measurements of Freshly Excised Breast Tissue to Histopathology

NCT02679378 is registered in ClinicalTrials.gov with Clear Cut Medical Ltd. as lead sponsor.

NCT NCT02679378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the ClearSight™ System to Evaluate the Ability to Distinguish Malignant From Non-malignant Breast Tissue by Comparing MR Measurements of Freshly Excised Breast Tissue to Histopathology
Lead sponsor
Clear Cut Medical Ltd.
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
November 30, 2018
Enrollment
220 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer